<unk> (nasal spray) is a serotonin (5‑HT) 1B/1D receptor agonist that is FDA approved for the treatment of migraine with or without aura in adults.   Common adverse reactions include unusual taste, paresthesia, dizziness, and hyperesthesia.
Zolmitriptan 
Sumatriptan 
Eletriptan
Rizatriptan
Frovatriptan
Almotriptan
Naratriptan
Olopatadine 